The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study
Shlomit Strulov Shachar(Tel Aviv University), Grant R. Williams(University of Alabama at Birmingham), Avital Bareket‐Samish, Itamar Shafran(Tel Aviv University), Gil Bar‐Sela(Emek Medical Center), Mira Wollner(Technion – Israel Institute of Technology), Mor Moskovitz(Rambam Health Care Campus), Jessica Epstein(Tel Aviv Sourasky Medical Center), Avivit Peer(Technion – Israel Institute of Technology), Amit Boukal(Technion – Israel Institute of Technology)
Cited by 11
Related Papers
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors
|Journal of Thoracic Oncology|2018|220
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
|Journal of Clinical Oncology|2024|131
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data
|Lung Cancer|2017|104
ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
|Clinical Lung Cancer|2016|100
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)
|Journal of Thoracic Oncology|2022|97